Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI.
Deborah M F van den BuijsAdriaan WilgenhofPaul KnaapenCarlo ZivelonghiThomas A MeijersPaul VermeerschFatih ArslanNiels VeroudenAlex NapKrischan SjauwFloris S van den BrinkPublished in: Journal of interventional cardiology (2022)
In patients with CHIP, there were no significant differences in hemodynamic instability and overall MACE between VA-ECMO or Impella CP device as mechanical circulatory support. Based on this study, the choice of either VA-ECMO or Impella CP does not alter the outcome.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- patients undergoing
- respiratory failure
- coronary artery disease
- acute coronary syndrome
- acute myocardial infarction
- percutaneous coronary intervention
- mechanical ventilation
- high throughput
- antiplatelet therapy
- circulating tumor cells
- heart failure
- atrial fibrillation
- st segment elevation myocardial infarction
- intensive care unit
- decision making
- left ventricular assist device